These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 6074943
21. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis]. Utkin VV, Rudoĭ NM. Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381 [No Abstract] [Full Text] [Related]
22. Ethionamide, pyrazinamide and cycloserine in drug resistant cases. Narang RK, Singh SK. Indian J Chest Dis; 1973 Jan; 15(1):16-20. PubMed ID: 4695462 [No Abstract] [Full Text] [Related]
23. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy]. Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204 [No Abstract] [Full Text] [Related]
24. Clinical efficiency of cycloserine in association with other tuberculostatics. Anastasatu C, Ulpian C, Weiss P. Scand J Respir Dis Suppl; 1970 Jun; 71():152-4. PubMed ID: 5271976 [No Abstract] [Full Text] [Related]
25. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital]. Sirota DS, Man'kovetskiĭ EF, Koĭfman SG, Vatsyk MZ. Probl Tuberk; 1974 Jun; (10):17-9. PubMed ID: 4370967 [No Abstract] [Full Text] [Related]
26. [Preparations of the 2d series in the complex treatment of middle-aged and elderly patients with pulmonary tuberculosis]. Iaschenko BP. Probl Tuberk; 1967 Jun; 45(9):21-6. PubMed ID: 4303748 [No Abstract] [Full Text] [Related]
27. Limitations of the clinical activity of cycloserine therapy. Appearance of resistance to cycloserine when used alone and in combination with other drugs. Molina C. Scand J Respir Dis Suppl; 1970 Jun; 71():296-305. PubMed ID: 5272000 [No Abstract] [Full Text] [Related]
28. Treatment of pulmonary tuberculosis with ethionamide, cycloserine and pyrazinamide in Hong Kong. Horsfall PA. Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():91-100. PubMed ID: 4662516 [No Abstract] [Full Text] [Related]
29. [Triple drug regimen with reserve drugs: ETA, PZA and CS in the treatment of chronic pulmonary tuberculosis]. Wagner J. Gruzlica; 1966 Mar; 34(3):249-54. PubMed ID: 5947778 [No Abstract] [Full Text] [Related]
30. Position of cycloserine in the treatment of pulmonary tuberculosis. Meyer A, Nadjar G. Scand J Respir Dis Suppl; 1970 Mar; 71():139-43. PubMed ID: 5271974 [No Abstract] [Full Text] [Related]
33. [Triple reserved scheme in the treatment of resistent forms of pulmonary tuberculosis (preliminary results)]. Rizzo A, Magalhães M, Moura N. Rev Bras Med; 1969 Sep; 26(9):504-10. PubMed ID: 5381888 [No Abstract] [Full Text] [Related]
40. Results of treatment of patients with pulmonary tuberculous with a combination of cycloserine and other tuberculostatics. Raboukhine A. Scand J Respir Dis Suppl; 1970 Oct; 71():155-8. PubMed ID: 5271977 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]